Literature DB >> 30538196

Cofactors are essential constituents of stable and seeding-active tau fibrils.

Yann Fichou1, Yanxian Lin2, Jennifer N Rauch3,4, Michael Vigers5, Zhikai Zeng6, Madhur Srivastava7, Timothy J Keller6, Jack H Freed7, Kenneth S Kosik3,4, Songi Han1,5.   

Abstract

Amyloid fibrils are cross-β-rich aggregates that are exceptionally stable forms of protein assembly. Accumulation of tau amyloid fibrils is involved in many neurodegenerative diseases, including Alzheimer's disease (AD). Heparin-induced aggregates have been widely used and assumed to be a good tau amyloid fibril model for most biophysical studies. Here we show that mature fibrils made of 4R tau variants, prepared with heparin or RNA, spontaneously depolymerize and release monomers when their cofactors are removed. We demonstrate that the cross-β-sheet assembly formed in vitro with polyanion addition is unstable at room temperature. We furthermore demonstrate high seeding capacity with transgenic AD mouse brain-extracted tau fibrils in vitro that, however, is exhausted after one generation, while supplementation with RNA cofactors resulted in sustained seeding over multiple generations. We suggest that tau fibrils formed in brains are supported by unknown cofactors and inhere higher-quality packing, as reflected in a more distinct conformational arrangement in the mouse fibril-seeded, compared with heparin-induced, tau fibrils. Our study suggests that the role of cofactors in tauopathies is a worthy focus of future studies, as they may be viable targets for diagnosis and therapeutics.

Entities:  

Keywords:  DEER; aggregate cofactors; amyloid aggregates; seeding; tau

Mesh:

Substances:

Year:  2018        PMID: 30538196      PMCID: PMC6310788          DOI: 10.1073/pnas.1810058115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Biology of amyloid: structure, function, and regulation.

Authors:  Jason Greenwald; Roland Riek
Journal:  Structure       Date:  2010-10-13       Impact factor: 5.006

2.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

Authors:  D M Wilson; L I Binder
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  Nuclear tau, a key player in neuronal DNA protection.

Authors:  Audrey Sultan; Fabrice Nesslany; Marie Violet; Séverine Bégard; Anne Loyens; Smail Talahari; Zeyni Mansuroglu; Daniel Marzin; Nicolas Sergeant; Sandrine Humez; Morvane Colin; Eliette Bonnefoy; Luc Buée; Marie-Christine Galas
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

4.  Heparin-induced tau filaments are structurally heterogeneous and differ from Alzheimer's disease filaments.

Authors:  Yann Fichou; Michael Vigers; Andrew K Goring; Neil A Eschmann; Songi Han
Journal:  Chem Commun (Camb)       Date:  2018-05-01       Impact factor: 6.222

5.  RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments.

Authors:  T Kampers; P Friedhoff; J Biernat; E M Mandelkow; E Mandelkow
Journal:  FEBS Lett       Date:  1996-12-16       Impact factor: 4.124

Review 6.  Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

Authors:  Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

7.  RNA sequestration to pathological lesions of neurodegenerative diseases.

Authors:  S D Ginsberg; J E Galvin; T S Chiu; V M Lee; E Masliah; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  1998-11       Impact factor: 17.088

8.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

9.  Conformation determines the seeding potencies of native and recombinant Tau aggregates.

Authors:  Benjamin Falcon; Annalisa Cavallini; Rachel Angers; Sarah Glover; Tracey K Murray; Luanda Barnham; Samuel Jackson; Michael J O'Neill; Adrian M Isaacs; Michael L Hutton; Philip G Szekeres; Michel Goedert; Suchira Bose
Journal:  J Biol Chem       Date:  2014-11-18       Impact factor: 5.157

10.  Amplification of Tau fibrils from minute quantities of seeds.

Authors:  Virginia Meyer; Paul D Dinkel; Emily Rickman Hager; Martin Margittai
Journal:  Biochemistry       Date:  2014-08-29       Impact factor: 3.162

View more
  27 in total

Review 1.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

Review 2.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

3.  Biophysical properties of a tau seed.

Authors:  Zhiqiang Hou; Dailu Chen; Bryan D Ryder; Lukasz A Joachimiak
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

4.  Liquid-liquid phase separation of Tau by self and complex coacervation.

Authors:  Saeed Najafi; Yanxian Lin; Andrew P Longhini; Xuemei Zhang; Kris T Delaney; Kenneth S Kosik; Glenn H Fredrickson; Joan-Emma Shea; Songi Han
Journal:  Protein Sci       Date:  2021-05-19       Impact factor: 6.993

5.  Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord.

Authors:  Jennifer A Macdonald; Iraad F Bronner; Lesley Drynan; Juan Fan; Annabelle Curry; Graham Fraser; Isabelle Lavenir; Michel Goedert
Journal:  Acta Neuropathol Commun       Date:  2019-03-18       Impact factor: 7.801

Review 6.  The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?

Authors:  Yann Fichou; Youssra K Al-Hilaly; François Devred; Caroline Smet-Nocca; Philipp O Tsvetkov; Joke Verelst; Joris Winderickx; Nick Geukens; Eugeen Vanmechelen; Audrey Perrotin; Louise Serpell; Bernard J Hanseeuw; Miguel Medina; Luc Buée; Isabelle Landrieu
Journal:  Acta Neuropathol Commun       Date:  2019-03-01       Impact factor: 7.801

7.  Tau protein- induced sequestration of the eukaryotic ribosome: Implications in neurodegenerative disease.

Authors:  Senjuti Banerjee; Sehnaz Ferdosh; Amar Nath Ghosh; Chandana Barat
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

8.  Protein Amyloid Cofactors: Charged Side-Chain Arrays Meet Their Match?

Authors:  Emily Lewkowicz; Shobini Jayaraman; Olga Gursky
Journal:  Trends Biochem Sci       Date:  2021-06-28       Impact factor: 13.807

Review 9.  The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology.

Authors:  Dylan Mah; Jing Zhao; Xinyue Liu; Fuming Zhang; Jian Liu; Lianchun Wang; Robert Linhardt; Chunyu Wang
Journal:  Front Mol Biosci       Date:  2021-05-20

10.  Phosphorylation and O-GlcNAcylation of the PHF-1 Epitope of Tau Protein Induce Local Conformational Changes of the C-Terminus and Modulate Tau Self-Assembly Into Fibrillar Aggregates.

Authors:  François-Xavier Cantrelle; Anne Loyens; Xavier Trivelli; Oliver Reimann; Clément Despres; Neha S Gandhi; Christian P R Hackenberger; Isabelle Landrieu; Caroline Smet-Nocca
Journal:  Front Mol Neurosci       Date:  2021-06-17       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.